Pharma and Healthcare (Q1FY25E Results Preview): Start the Year on a Strong Nod
The India Pharma & Healthcare sector is expected to maintain the growth momentum in Q1FY25E. We expect our coverage universe to see 11%/13% YoY...
378 Views
Pharmaceuticals: US Generic Growth to Stay, Selective on Structural Play
The pharmaceutical sector, emerging from the volatility of the past two post-pandemic and geopolitically tumultuous years, is now on a recovery...
324 Views
Sun Pharmaceutical Industries: Innovative Medicines and India Key Drivers. Maintain BUY
We recently interacted with the senior management of Sun Pharma—Ms. Jayashree Satagopan, CFO, and Dr. Abhishek Sharma, Head IR.
598 Views
Sun Pharmaceutical Industries: Halol Observations Were Critical, No Relief to Plant.
Sun Pharma’s (SUNP) formulation manufacturing facility at Halol (Gujarat, India) had an inspection from the USFDA for current Good Manufacturing...
652 Views
Sun Pharmaceutical Industries: Checkpoint Acquisition to Strengthen Specialty Business.
Sun Pharma (SUNP) and Checkpoint Therapeutics Inc (Checkpoint) have entered into an agreement under which SUNP will acquire Checkpoint, an...
351 Views